Maxine V. Holder

Maxine V. Holder

Auto-generated profile, based on publicly available information

Maxine V. Holder

Apoptosis and Proliferation Control Laboratory, The Francis Crick Institute, London, United Kingdom

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Molecular Therapy
Verified
Journal Article
Open access
MTMichael Themis
Michael Themis
SWSimon Waddington
Simon Waddington
MSManfred Schmidt
Manfred Schmidt
CKChristof von Kalle
Christof von Kalle
YWYoahe Wang
Yoahe Wang
CCCharles Coutelle
Charles Coutelle
Gene therapy by use of integrating vectors carrying therapeutic transgene sequences offers the potential for a permanent cure of genetic diseases by stable vector insertion into the patients' chromosomes. However, three cases of T cell lymphoproliferative disease have been identified almost 3 years after retrovirus gene therapy for X-linked severe combined immune deficiency. In two of these cases vector insertion into the LMO2 locus was implicated in leukemogenesis, demonstrating that a more profound understanding is required of the genetic and molecular effects imposed on the host by vector integration or transgene expression. In vivo models to test for retro- and lentiviral vector safety prior to clinical application are therefore needed. Here we present a high incidence of lentiviral vector-associated tumorigenesis following in utero and neonatal gene transfer in mice. This system may provide a highly sensitive model to investigate integrating vector safety prior to clinical application.

1 January 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KAKen Arita
Ken Arita
ASAndrew P. South
Andrew P. South
GHGünter Hans-Filho
Günter Hans-Filho
TSThais Harumi Sakuma
Thais Harumi Sakuma
JLJoey Lai-Cheong
Joey Lai-Cheong
JMJohn A. McGrath
John A. McGrath

1 November 2004 in Blood
Verified
Journal Article
Closed access
PDF file
SWSimon Waddington
Simon Waddington
MNMegha S. Nivsarkar
Megha S. Nivsarkar
AMAjay R. Mistry
Ajay R. Mistry
SBSuzanne M. K. Buckley
Suzanne M. K. Buckley
GKGeoffrey Kemball-Cook
Geoffrey Kemball-Cook
CCCharles Coutelle
Charles Coutelle
Hemophilia B, also known as Christmas disease, arises from mutations in the factor IX ( F9 ) gene. Its treatment in humans, by recombinant protein substitution, is expensive, thus limiting its application to intermittent treatment in bleeding episodes and prophylaxis during surgery; development of inhibitory antibodies is an associated hazard. This study demonstrates permanent therapeutic correction of his disease without development of immune reactions by introduction of an HIV-based lentiviral vector encoding the human factor IX protein into the fetal circulation of immunocompetent hemophiliac and normal outbred mice. Plasma factor IX antigen remained at around 9%, 13%, and 16% of normal in the 3 hemophilia B mice, respectively, until the last measurement at 14 months. Substantial improvement in blood coagulability as measured by coagulation assay was seen in all 3 mice and they rapidly stopped bleeding after venipuncture. No humoral or cellular immunity against the protein, elevation of serum liver enzymes, or vector spread to the germline or maternal circulation were detected. (Blood. 2004;104: 2714-2721)

1 March 2018 in Development
Verified
Journal Article
Open access
PDF file
GFGeorgina C. Fletcher
Georgina C. Fletcher
MDMaria-Del-Carmen Diaz-De-La-Loza
Maria-Del-Carmen Diaz-De-La-Loza
NBNerea Borreguero-Muñoz
Nerea Borreguero-Muñoz
MHMaxine Holder
Maxine Holder
MAMario Aguilar-Aragon
Mario Aguilar-Aragon
Barry ThompsonBarry Thompson
Barry Thompson
Animal cells are thought to sense mechanical forces via the transcriptional co-activators YAP (or YAP1) and TAZ (or WWTR1), the sole Drosophila homolog of which is named Yorkie (Yki). In mammalian cells in culture, artificial mechanical forces induce nuclear translocation of YAP and TAZ. Here, we show that physiological mechanical strain can also drive nuclear localisation of Yki and activation of Yki target genes in the Drosophila follicular epithelium. Mechanical strain activates Yki by stretching the apical domain, reducing the concentration of apical Crumbs, Expanded, Kibra and Merlin, and reducing apical Hippo kinase dimerisation. Overexpressing Hippo kinase to induce ectopic activation in the cytoplasm is sufficient to prevent Yki nuclear localisation even in flattened follicle cells. Conversely, blocking Hippo signalling in warts clones causes Yki nuclear localisation even in columnar follicle cells. We find no evidence for involvement of other pathways, such as Src42A kinase, in regulation of Yki. Finally, our results in follicle cells appear generally applicable to other tissues, as nuclear translocation of Yki is also readily detectable in other flattened epithelial cells such as the peripodial epithelium of the wing imaginal disc, where it promotes cell flattening.

23 December 2012 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
MWMichael C. Wehr
Michael C. Wehr
MHMaxine V. Holder
Maxine V. Holder
IGIeva Gailite
Ieva Gailite
RSRebecca E. Saunders
Rebecca E. Saunders
TMTobias M. Maile
Tobias M. Maile
NTNicolas Tapon
Nicolas Tapon
The specification of tissue size during development involves the coordinated action of many signalling pathways responding to organ-intrinsic signals, such as morphogen gradients, and systemic cues, such as nutrient status. The conserved Hippo (Hpo) pathway, which promotes both cell-cycle exit and apoptosis, is a major determinant of size control. The pathway core is a kinase cassette, comprising the kinases Hpo and Warts (Wts) and the scaffold proteins Salvador (Sav) and Mats, which inactivates the pro-growth transcriptional co-activator Yorkie (Yki). We performed a split-TEV-based genome-wide RNAi screen for modulators of Hpo signalling. We characterize the Drosophila salt-inducible kinases (Sik2 and Sik3) as negative regulators of Hpo signalling. Activated Sik kinases increase Yki target expression and promote tissue overgrowth through phosphorylation of Sav at Ser 413. As Sik kinases have been implicated in nutrient sensing, this suggests a link between the Hpo pathway and systemic growth control.

1 March 2015 in Current Biology
Verified
Journal Article
Closed access
PGPedro Gaspar
Pedro Gaspar
MHMaxine V. Holder
Maxine V. Holder
BABirgit L. Aerne
Birgit L. Aerne
Florence JanodyFlorence Janody
Florence Janody
NTNicolas Tapon
Nicolas Tapon